| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anemia Treatment After 30 Years of Erythropoietic Stimulating Agents: No Longer Business as Usual?
|
Wish, Jay B.
|
|
2019
|
26 |
4 |
p. 225-228
|
artikel
|
| 2 |
Biosimilar Erythropoiesis-Stimulating Agents in Chronic Kidney Disease
|
Shah, Hitesh H.
|
|
2019
|
26 |
4 |
p. 267-271
|
artikel
|
| 3 |
Editorial Board
|
|
|
2019
|
26 |
4 |
p. A2
|
artikel
|
| 4 |
Erythropoiesis-Stimulating Agents and Cancer: Myth or Truth
|
Choi, Michael J.
|
|
2019
|
26 |
4 |
p. 221-224
|
artikel
|
| 5 |
Hepcidin
|
Agarwal, Anil K.
|
|
2019
|
26 |
4 |
p. 298-305
|
artikel
|
| 6 |
Hypoxia-Inducible Factor Activators in Renal Anemia: Current Clinical Experience
|
Sanghani, Neil S.
|
|
2019
|
26 |
4 |
p. 253-266
|
artikel
|
| 7 |
Long-Term Risks of Intravenous Iron in End-Stage Renal Disease Patients
|
Kshirsagar, Abhijit V.
|
|
2019
|
26 |
4 |
p. 292-297
|
artikel
|
| 8 |
Low Quality of International Classification of Diseases, 10th Revision, Procedural Coding System Data Undermines the Validity of the Standardized Transfusion Ratio: Time to Chart a New Course?
|
Weinhandl, Eric D.
|
|
2019
|
26 |
4 |
p. 237-249
|
artikel
|
| 9 |
Masthead
|
|
|
2019
|
26 |
4 |
p. A1
|
artikel
|
| 10 |
Novel Oral Iron Therapies for Iron Deficiency Anemia in Chronic Kidney Disease
|
Pergola, Pablo E.
|
|
2019
|
26 |
4 |
p. 272-291
|
artikel
|
| 11 |
Table of Contents
|
|
|
2019
|
26 |
4 |
p. A4-A5
|
artikel
|
| 12 |
The Evolution of Target Hemoglobin Levels in Anemia of Chronic Kidney Disease
|
Bazeley, Jonathan
|
|
2019
|
26 |
4 |
p. 229-236
|
artikel
|
| 13 |
The Impact of Anemia Treatment on Health-Related Quality of Life in Patients With Chronic Kidney Disease in the Contemporary Era
|
Finkelstein, Fredric O.
|
|
2019
|
26 |
4 |
p. 250-252
|
artikel
|
Tijdschrift beschrijving